3.4 Peds 2 Flashcards
(92 cards)
APGAR
appearance, pulse, grimace, activity, respiration
APGAR score
a physiologic assessment tied to probability of survival
apgar scoring
scored at 1 and 5 minutes following birth.
5 functions evaluated scored from 0-2.
perfect score of 10.
chart
on slide 3
if apgar scre is 0 to 1 at 5 min
50% mortality in first 28 days.
Drops to 20% with a score of 4
score of 7 or more
almost 0% mortality
apgar score correlates with
survival NOT normal life thereafter
Fetal Hydrops
accumulation of edema in fetus during IU growth.
hydrops fetalis
progressive generalized
cystic hygroma
localized
fetal hydrops can be classified as
immune (mother ab to fetal RBC) and
non immune hydrops (most common)
immune hydrops
hemolytic disease due to blood group incompatability btw mother/fetus
most common cause of immune hydrops
Rh incompatablitty – most due to classic Rh incompatibility btw Rh (-) mother and 2nd Rh(+) child (D ag)
C D and E ag
cause of incompatibility but most common is C
response of mother
1st Rh+ child to Rh- mother can sensitize late in pregnancy when barrier cytotrophoblast not present.
1st child evokes 1gM Abs but they cant cross placenta so no disease.
2nd Rh+ child evokes IgG that can cross so you see the disease damaging fetal RBCs causing hemolytic anemia
clinical presentations of erythroblastosis fetalsis
hemolytic anemia, congestive heart failure, hepatospenomegaly, edema, jaundice, kernicterus
kernicterus
biliruben in the brain - neural damage usually with billirubin >20mg/dl
immune hydrops - factors that influence immune response to Rh+ fetal RBC
concurrent ABO incompatibility can prevent sensitization to Rh,
maternal response is dose dependent.
Needs more than 1ml of fetal cells
immune hydrops - prevention
administration of rhesus anti-D globulin (Rhogam) to mothers at 28w and w/in 72hrs of delivery greatly reduced rate of immune hydrops.
Also following abortions
immune hydrops - antenatal identification of at risk fetus
blood typing, indirect coombs. Ab screening, amniocentesis, chronic villi and fetal blood sampling (fetal genotyping),
now NIPD -non invasive prenatal diagnosis - RHD genotyping of fetuses using maternal blood
immune hydrops - treatment
if hemolysis occurs inutero, treat by IU transfusion.
Delivery (if mature), phenobarbital.
Phototherapy (reduce bilirubine to a way to be excreted) and
exchange transfusion
cystic hygroma
commonly occurs in neck, abdomen and associated with Turner’s syndrome (45X)
immune hydrops -maternal fetal ABO incompatibility
mild, 20-25% of pregnancies,
lab evidence of hemolytic disease in 1/10,
requre treatment in 1/200 cases,
bc of low rh incompatibiliyt, abo incomatability became the main cause of hemolytic disease of the new born,
some “O” motheres have preformed IgG anti A and B, therefor first born can be affected, no effective prophylaxis against ABO rxn
immune hydrops - why low incided of hydrops in ABO incompatibility?
most anti A and B are IgM. Do not corss the placenta. Fetal cells express AgA and B poorly. Most other cells also express AgA and B so absorb some transferred Abs